Cargando…

15. Real-World Changes in Clostridioides difficile infection (CDI) Treatment Utilization and Clinical Outcomes Associated with Updated 2017 IDSA Guidelines among Medicare Beneficiaries in the U.S

BACKGROUND: The 2017 IDSA CDI guideline update phased out metronidazole (MTZ) and recommended vancomycin (VAN) or fidaxomicin (FDX) for first-line use. This study examined changes in CDI antibiotic use and clinical outcomes among Medicare beneficiaries with CDI pre- vs. post- the guideline update. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Dubberke, Erik R, Puckett, Justin T, Obi, Engels N, Kamal-Bahl, Sachin, Desai, Kaushal, Stuart, Bruce, Doshi, Jalpa A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643958/
http://dx.doi.org/10.1093/ofid/ofab466.015

Ejemplares similares